PMID: 16538101Mar 16, 2006Paper

Individualization of antiviral treatment regimens for chronic hepatitis C

European Journal of Gastroenterology & Hepatology
Emma Paulon, Nikolai V Naoumov

Abstract

The treatment of patients with chronic hepatitis C has rapidly evolved in the past 10 years. The introduction of ribavirin and, more recently, its combination with pegylated interferon represent two landmark changes in improving the treatment efficacy. Overall, sustained virological response at present can be expected in 43-46% of patients infected with genotype 1 and 75-80% in genotype 2 or 3 infection. In addition, factors associated with a lower or greater chance of response to treatment have now been identified, thus providing a basis for modifying current therapy according to the needs of different patient groups. Accumulating evidence demonstrates that individualized treatment regimens, according to the timing of treatment-induced viral clearance, provide a safe and cost-effective approach, as well as an improvement in treatment efficacy.

References

Jul 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N P LamT J Layden
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A SangiovanniG Minoli
Aug 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K R ReddyT Joh
Dec 7, 2000·The New England Journal of Medicine·E J HeathcoteJ De Pamphilis
Mar 7, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L J YeeR A Kaslow
Oct 27, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M Martinot-PeignouxP Marcellin
Jul 30, 2002·Gastroenterology·Haruhiko YoshidaMasao Omata
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
May 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jennifer E Layden-AlmerThomas J Layden
May 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eva HerrmannStefan Zeuzem
Aug 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gary L DavisJanice Albrecht
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Mar 20, 2004·Journal of Hepatology·Johannes T BrouwerUNKNOWN Benelux Study Group On Treatment Of Chronic Hepatitis C
Jun 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lennox J JeffersK Rajender Reddy
Sep 16, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hermann E WasmuthFrank Lammert
Nov 24, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Olav DalgardHelge Bell
Dec 4, 2004·Gastroenterology·Stefan ZeuzemUNKNOWN PEGASYS Study NR16071 Investigator Group
Jan 19, 2005·Journal of Viral Hepatitis·M WrightUNKNOWN UK Mild HCV Trial investigators
Jan 20, 2005·Annals of Internal Medicine·Yasushi ShiratoriUNKNOWN Tokyo-Chiba Hepatitis Research Group
Mar 24, 2005·The American Journal of Gastroenterology·Akinari TabaruMakoto Otsuki
May 10, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shengyuan LuoCharles D Howell
Jun 24, 2005·The New England Journal of Medicine·Alessandra MangiaAngelo Andriulli

❮ Previous
Next ❯

Citations

Nov 16, 2006·Expert Opinion on Therapeutic Targets·Daniel YerlyAndreas Cerny

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.